![]() |
||
| Home | Firm Description | Sectors Covered | Completed Transactions | Testimonials | Principals | M&A Report and Publications |
Contact Us |
| Acquiring Party | Apria Healthcare Group Inc., a major provider of home respiratory therapy, infusion therapy and medical equipment. |
|---|---|
| Transferring Party | Coram Inc., a privately-owned provider of home infusion and specialty pharmaceutical services, with 2,100 employees, 70 home infusion brances and 50 ambulatory infusion suites. |
| Sector | Medical Services |
| Date | December 4, 2007 |
| Analysis Enables Apria to enter the rapidly-growing specialty pharmaceutical market, while expanding existing managed care relationships associated with its respiratory/home medical equipment business. Also makes Apria significantly less reliant on government reimbursement policies. Corurm provides specialty pharmaceuticals, drug delivery and clinical management services to patients with chronic or rare conditions. The two organizations care for more than 100,000 patients annually in all 50 states. Deal value -- $350m, on expected 08 Corum revenue of $500m (0.7x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |